Leqvio (Inclisiran): Uses, Side Effects, Dosage & Safety
Quick summary: Leqvio (inclisiran) is an injectable medicine used to help lower LDL cholesterol in certain people. It is given by a healthcare professional, and the usual schedule described in the source content is...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Leqvio (inclisiran) is an injectable medicine used to help lower LDL cholesterol in certain people. It is given by a healthcare professional, and the usual schedule described in the source content is an initial dose, a second dose after 3 months, then every 6 months.
Commonly mentioned side effects include injection site reactions, joint pain, cough or nasal congestion, fatigue, and nausea. Always check the official leaflet and speak with a clinician or pharmacist about your own situation.
Medical disclaimer: This article is for general information only and does not replace advice from a qualified healthcare professional. It does not diagnose, treat, or recommend changes to any medicine. If you have symptoms, questions about dosing, pregnancy, breastfeeding, liver health, or a missed dose, contact your prescriber, pharmacist, or local emergency service as appropriate.
What is Leqvio?
Leqvio (inclisiran) is an injectable therapy used to help manage cholesterol levels, especially in people with familial hypercholesterolemia and other hyperlipidemia conditions. The source content describes it as a treatment that targets the PCSK9 enzyme, helping the liver remove LDL cholesterol from the bloodstream.
Because it is given as an injection by a healthcare professional, it is usually discussed as part of a broader cholesterol-management plan rather than as a stand-alone solution.
How Leqvio is given
Leqvio is described in the source content as a pre-filled injection, typically containing 284 mg/1.5 mL. Administration is performed by a healthcare professional.
The dosing schedule described is:
- An initial dose
- A second dose after 3 months
- Ongoing doses every 6 months
Patients should follow the schedule provided by their own healthcare team, since treatment plans can vary.
Common side effects of Leqvio
Like all medicines, Leqvio can cause side effects. The source content lists the following as commonly reported:
- Injection site reactions such as redness or swelling
- Joint pain
- Cough or nasal congestion
- Fatigue or a general feeling of malaise
- Nausea
These effects are described as generally mild in the source content, but persistent or troublesome symptoms should be discussed with a healthcare professional.
Long-term side effects and monitoring
The source content notes that long-term effects are still being studied. It also highlights two important areas to watch for over time:
- Serious allergic reactions, which may include swelling, hives, or difficulty breathing
- Changes in liver enzymes, which may be checked with blood tests during treatment
Regular follow-up helps clinicians monitor how treatment is going and whether any new concerns appear.
Warnings and precautions
Before treatment, the source content says patients should discuss the following with their healthcare team:
- Any known allergy to inclisiran or ingredients in the formulation
- Pregnancy or breastfeeding
- Liver disease or liver-related concerns
- All other medicines currently being taken
This helps the prescriber assess whether Leqvio is appropriate and whether extra monitoring is needed.
Missed dose and overdose
If a dose is missed, the source content says it should be given as soon as remembered unless it is close to the next scheduled dose. In that case, the missed dose is skipped and the regular schedule continues.
Do not double a dose to make up for a missed one.
If an overdose is suspected, seek immediate medical attention, even if symptoms are not obvious.
Contraindications
The source content identifies a known allergy to inclisiran or any ingredient in the formulation as the main contraindication.
It also advises caution in people with severe liver disease or dysfunction. A healthcare professional should review the full medical history before treatment is started.
What to verify with a doctor or pharmacist
If you are reading about Leqvio for yourself or someone else, it can help to confirm the following with a clinician or pharmacist:
- Why the medicine has been prescribed
- The exact injection schedule being used
- Which side effects should be reported promptly
- Whether liver tests or other monitoring are planned
- How pregnancy, breastfeeding, or other medicines may affect treatment
Safety reminder
If you notice signs of a serious allergic reaction, such as swelling, hives, or breathing difficulty, seek urgent medical help. For any new or worsening symptoms, contact a healthcare professional promptly. Always use the official patient leaflet and your prescriber’s instructions as the most reliable source for your own treatment plan.
Frequently asked questions
▸ What is Leqvio used for?
The source content says Leqvio is used to help manage cholesterol levels, especially in familial hypercholesterolemia and other hyperlipidemia conditions.
▸ What are the most common side effects?
The commonly listed side effects are injection site reactions, joint pain, cough or nasal congestion, fatigue, and nausea.
▸ How often is Leqvio given?
The source content describes an initial dose, a second dose after 3 months, and then doses every 6 months.
▸ Can Leqvio cause long-term side effects?
The source content says long-term effects are still being studied. It also notes possible serious allergic reactions and the need to monitor liver enzymes.
▸ What should I do if I miss a dose?
The source content says to take the missed dose as soon as you remember unless it is close to the next scheduled dose. Do not double the dose.
▸ Is Leqvio safe during pregnancy or breastfeeding?
The source content says safety during pregnancy and breastfeeding has not been fully established, so this should be discussed with a healthcare professional.
Key takeaways
Leqvio (inclisiran) is an injectable cholesterol-lowering medicine given on a long-interval schedule. The source content highlights common side effects, the need for monitoring, and the importance of checking allergies, liver health, pregnancy, breastfeeding, and other medicines with a healthcare professional.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
- FDA Prescribing Information for Leqvio (inclisiran)
- EMA Product Information for Leqvio
- NHS Medicines Information: Inclisiran
- Mayo Clinic: Inclisiran injection
To improve this article with specific references, add a custom field named _aio_sources in the post editor and write one source per line using: Source title|Source URL.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.